Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Probable fibrosin-1 (FBRS) is a protein secreted by activated lymphocytes and classified as a lymphokine, with probable growth factor activity. It is predicted to stimulate proliferation of fibroblasts and contributes to myofibroblast accumulation during wound healing, suggesting a putative role in scarring and fibrotic processes. The gene is protein-coding and associated with several conditions via gene-gene association studies; however, its mechanism and clinical significance are poorly characterized and not yet targeted by approved drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Probable fibrosin-1 (FBRS).